Guarding Against Digital Cell and Gene Therapy Cyberattacks Growing use of digital production technologies and automation is introducing vulnerabilities that could result in supply chain disruption. #EdisonBicudo Aston University #bioprocessing #biomanufacturing #CellTherapy #GeneTherapy
Genetic Engineering & Biotechnology News
Book and Periodical Publishing
New Rochelle, New York 182,675 followers
The Bedrock of Biotech
About us
Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Celebrating its 40th anniversary in 2021, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new tools and technologies, investment growth, and career opportunities. Through its cornerstone Magazine, dynamic Website, high-frequency eNewsletters, and innovative suite of multimedia, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their success. GEN’s breadth of editorial coverage is unrivaled, providing exclusive reporting, insight, and analysis across the life sciences – from its five foundational pillars of Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing to a new, expanded focus on the emerging areas of Cancer Research, Infectious Diseases, and Artificial Intelligence. Within these areas, GEN delivers exclusive, high-quality reporting on the latest industry news; insider information on cutting-edge tools and technologies; industry-standard protocols, tutorials, and technical articles; first-looks at emerging industry collaborations and investments; reports from key scientific and industry meetings; and A-Lists, our monthly insight and analysis into the top companies, products, and movers & shakers impacting the industry today.
- Website
-
http://www.genengnews.com
External link for Genetic Engineering & Biotechnology News
- Industry
- Book and Periodical Publishing
- Company size
- 51-200 employees
- Headquarters
- New Rochelle, New York
- Type
- Privately Held
- Founded
- 1981
- Specialties
- Biotechnology, Drug Discovery, Bioprocessing, Translational Medicine, OMICS, and Genome Editing
Locations
-
Primary
Get directions
140 Huguenot St
New Rochelle, New York 10801, US
Employees at Genetic Engineering & Biotechnology News
Updates
-
Aldevron Launches New Innovation Center The Waltham Innovation Center will complement Aldevron’s established scientific teams in Fargo, ND, and Madison, WI. Aldevron #geneediting #genomicmedicine #molecularbiology
-
AI-Led Bio Operations Management Celebrates Growing Industry Maturity According to Scott Drap, the company has also seen an increase in front-line customers scaling the Quartic software to work across multiple manufacturing facilities. #bioprocessing #ArtificialIntelligence #bioinformatics #InformationManagement #MonoclonalAntibodies
-
Expanding Expertise and Capabilities Propel CGT Institutes Academic institutes are shaping the future of personalized therapeutics through expanded in-house cGMP manufacturing facilities and increasingly tight integrations with industry. #ChrisChoi Roswell Park Comprehensive Cancer Center #bioprocessing #CellTherapy #DrugDiscovery
-
B Cell–Driven Immunometabolic Strategy Halts Liver Tumors in Mice Blocking a key metabolic enzyme helps B cells fight liver tumors, revealing a new immunotherapy pathway for fatty liver–driven cancer in mice. #GregorySteinbergPhD McMaster University Department of Medicine #immunotherapy #Bcells #livercancer
-
Digital Tools Improve Good-Practice Compliance Regulators around the world require compliance in Good Practice (GxP) regulations. These guidelines help ensure that products are fit for their intended use and comply with applicable regulatory standards. To learn more about how GxP impacts bioprocessors, GEN talked with Akshay Kapadia, CEO at Conexus Solutions, Inc. #bioprocessing #gmp #bioinformatics
-
Protein Synthesis Slowdown Implicated in Brain Aging in Killifish The study links aging organisms' inability to sustain production of key proteins to impaired translation and increased aggregation risk. Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) Stanford University #proteinsynthesis #brain #aging
-
New AI Tool, ShortStop, Searches the Genome for Microproteins Researchers used ShortStop to Identify a microprotein that potentially represents a biomarker or functional microprotein for lung cancer Salk Institute for Biological Studies #biomarker #lungcancer #AI
-
Vir Biotechnology Pivots to Cancer, Infectious Disease after Commercial and Clinical Setbacks The remainder of 2025 will be busy for Vir Biotechnology as it strives to successfully pivot to developing cancer and infectious disease therapies. #MarianneDeBackerPhD Vir Biotechnology, Inc. #cancer #infectiousdisease #therapeutics